What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 3, 2011, Pages 377-406

  Fernández Serrano, Maria Jose ^a   Pérez García, Miguel ^a   Verdejo García, Antonio ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Alcohol; Cannabis; Emotion; Executive functions; Memory; Neuropsychology; Opioids; Polysubstance use; Psychostimulants

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; CANNABINOID 1 RECEPTOR; CANNABIS; COCAINE; DOPAMINE RECEPTOR; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OPIATE DERIVATIVE; PSYCHOSTIMULANT AGENT;

ALCOHOLISM; BRAIN DAMAGE; BRAIN FUNCTION; CANNABIS ADDICTION; COCAINE DEPENDENCE; COGNITIVE DEFECT; DECISION MAKING; DRUG ABUSE; DRUG WITHDRAWAL; EMOTIONAL DISORDER; EMOTIONALITY; EPISODIC MEMORY; HUMAN; IMPULSIVENESS; MEMORY DISORDER; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NEUROTRANSMISSION; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; REVIEW; SEMANTIC MEMORY; SOCIAL BEHAVIOR; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

ANIMALS; COGNITION; COGNITION DISORDERS; HUMANS; NEUROPSYCHOLOGICAL TESTS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 78649906423     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2010.04.008     Document Type: Review

References (192)

1. Abi-Saab D., Beauvais J., Mehm J., Brody M., Gottschalk C., Kosten T.R. The effect of alcohol on the neuropsychological functioning of recently abstinent cocaine-dependent subjects. Am. J. Addict. 2005, 14(2):166-178.
2. Adams K.M., Brown G.G., Grant I. Analysis of covariance as a remedy for demographic mismatch of research subject groups: some sobering simulations. J. Clin. Exp. Neuropsychol. 1985, 7(4):445-462.
3. Aguilar de Arcos F., Verdejo-García A., Ceverino A., Montañez-Pareja M., López-Juárez E., Sánchez-Barrera M., López-Jiménez A., Pérez-García M. Dysregulation of emotional response in current and abstinent heroin users: negative heightening and positive blunting. Psychopharmacology 2008, 198:159-166.
4. Andrews P. Cocaethylene toxicity. J. Addict. Dis. 1997, 16(3):75-84.
5. Aron A.R., Behrens T.E., Smith S., Frank M.J., Poldrack R.A. Triangulating a cognitive control network using diffusion-weighted magnetic resonance imaging (MRI) and functional MRI. J. Neurosci. 2007, 27(14):3743-3752.
6. Beatty W.W., Borrel G.K. Forms of knowledge, cognitive impairment and drug abuse: a demonstration. Prog. Neuropsychoparmacol. Biol. Psychiatry 2000, 24:17-22.
7. Beatty W.W., Tivis R., Stott H.D., Nixon S.J., Parsons O.A. Neuropsychological deficits in sober alcoholics: influences of chronicity and recent alcohol consumption. Alcohol. Clin. Exp. Res. 2000, 24(2):149-154.
8. Bechara A. Decision-making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 2005, 8:1458-1463.
9. Bhattachary S., Powell J.H. Recreational use of 3-4-methyledioxymethanphetamine (MDMA) or "ecstasy": evidence for cognitive impairment. Psychol. Med. 2001, 31:647-658.
10. Bjork J., Hommer D., Grant S., Danube C. Impulsivity in abstinent alcohol-dependent patients: relation to control subjects and type 1-/type 2-like traits. Alcohol 2004, 34(2-3):133-150.
11. Bolla K.I., Eldreth D.A., London E.D., Kiehl K.A., Mouraditis M., Contoreggi C., Matochik J.A., Kurian V., Cadet J.-L., Kimes A.S., Fundeburk F.R., Ernst M. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage 2003, 19:1085-1094.
12. Bolla K.I., Funderburk F.R., Cadet J. Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology 2000, 54(12):2285-2292.
13. Bolla K.I., Rothman R., Cadet J.L. Dose-related neurobehavioral effects of chronic cocaine use. J. Neuropsychiatry Clin. Neurosci. 1999, 11:361-369.
14. Brand M., Roth-Bauer M., Driessen M., Markowitsch H.J. Executive functions and risky decision-making in patients with opiate dependence. Drug Alcohol Depend. 2008, 7:64-72.
15. Burns H.D., Van L.K., Sanabria-Bohorquez S., Hamill T.G., Bormans G., Eng W.S., Gibson R., Ryan C., Connolly B., Patel S., Krause S., Vanko A., Van H.A., Dupont P., De I L., Rothenberg P., Stoch S.A., Cote J., Hagmann W.K., Jewell J.P., Lin L.S., Liu P., Goulet M.T., Gottesdiener K., Wagner J.A.de H.J., Mortelmans L., Fong T.M., Hargreaves R.J. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:9800-9805.
16. Butler G.K., Montgomery A.M. Impulsivity, risk taking and recreational "ecstasy" (MDMA) use. Drug Alcohol Depend. 2004, 76:55-62.
17. Camí J., Farré M. Drug addiction. N. Engl. J. Med. 2003, 349:975-986.
18. Carroll K., Ziedonis D., O'Malley S., McCance-Katz E., Gordon L., Rounsaville A. Pharmacologic interventions for alcohol- and cocaine-abusing individuals: a pilot study of disulfiram vs naltrexone. Am. J. Addict. 1993, 2(1):77-79.
19. Cheng R.K., Etchegaray M., Meck W.H. Impairments in timing, temporal memory, and reversal learning linked to neurotoxic regimens of methamphetamine intoxication. Brain Res. 2007, 1186(19):255-266.
20. Clark D.B., Cornelius J.R., Kirisci L., Tarter R.E. Childhood risk categories for adolescent substance involvement: a general liability typology. Drug Alcohol Depend. 2005, 77:13-21.
21. Clark L., Robbins T.W., Ersche K.D., Sahakian B.J. Reflection impulsivity in current and former substance users. Biol. Psychiatry 2006, 60(5):515-522.
22. Clark L., Roiser J.P., Robbins T.W., Sahakian B.J. Disrupted 'reflection' impulsivity in cannabis users but not current or former ecstasy users. J. Psychopharmacol. 2009, 23(1):14-22.
23. Clemens K.J., Cornish J.L., Kong M.L., Kunt G.E., McGregor I.S. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. Neuropharmacology 2005, 49(2):195-207.
24. Colzato L.S., van den Wildenberg W.P.M., Hommel B. Impaired inhibitory control in recreational cocaine users. PLos ONE 2007, 2(11):e1143.
25. Colzato L.S., van den Wildenberg W.P.M., Hommel B. Reduced attentional scope in cocaine polydrug users. PLos One 2009, 4(6):6043.
26. Corbin W.R., Cronce J.M. Alcohol effects on behavioral control: the impact of likelihood and magnitude of negative consequences. Alcohol. Clin. Exp. Res. 2007, 31(6):955-964.
27. Croft R.J., Mackay A.J., Mills A.T.D., Gruzelier J.G.H. The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 2001, 153:373-379.
28. Curran H.V., Kleckham J., Bearn J., Strang J., Wanigaratne S. Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose response study. Psychopharmacology 2001, 154:153-160.
29. Dafters R.I. Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions. Drug Alcohol Depend. 2006, 83(3):181-184.
30. Dafters R.I., Hoshi R., Talbot A.C. Contribution of cannabis and MDMA (" ecstasy") to cognitive changes in long-term polydrug users. Psychopharmacology 2004, 173:405-410.
31. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K., Pena Y., Murphy E.R., Shah Y., Probst K., Abakumova I., Aigbirhio F.I., Richards H.K., Hong Y., Baron J.C., Everitt B.J., Robbins T.W. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
32. Davis P.E., Liddiard H., McMillan T.M. Neuropsychological deficits and opiate abuse. Drug Alcohol Depend. 2002, 67:105-108.
33. Deadwyler S.A., Goonawardena A.V., Hampson R.E. Short-term memory is modulated by the spontaneous release of endocannabinoids: evidence from hippocampal population codes. Behav. Pharmacol. 2007, 18:571-580.
34. De Sola S., Miguelez-Pan M., Peña-Casanova J., Poudevida S., Farré M., Pacifini R., Böhm P., Abanades S., Verdejo-García A., Zuccaro P., De la Torre R. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. J. Psychopharmacol. 2008, 200:425-437.
35. de Win M.M.L., Jager G., Verkaeke H.K.E., Schilt T., Reneman L., Booij J., Verhulst F.C., Den Heeten G.J., Ramsey N.F., Korf D.J., Van den Brink W. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. Int. J. Methods Psychiatr. Res. 2005, 14:167-185.
36. Di Sclafani V., Tolou-Shams M., Price L.J., Fein G. Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend. 2002, 66:161-171.
37. Dumont G.J.H., Valkenberg M.M.G.J., Schoemaker R., Buitelaar J.K., van Gerven J.M.A., Verkes R.J. Acute MDMA and ethanol interaction effects on psychomotor performance. Br. J. Clin. Pharmacol. 2007, 63:503.
38. Dumont G.J.H., Wezenberg E., Valkenberg M.M.G.J., de Jong C.A.J., Buitelaar J.K., van Gerven J.M.A., Verkes R.J. Acute neuropsychological effects of MDMA and etanol (co-) administration in healthy volunteers. Psychopharmacology 2008, 197:465-474.
39. Errico A.L., King A.C., Lovallo W.R., Parsons O.A. Cortisol dysregulation and cognitive impairment in abstinent male alcoholics. Alcohol. Clin. Exp. Res. 2002, 26:1198-1204.
40. Ersche K.D., Clark L., London M., Robbins T.W., Sahakian B.J. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 2006, 31:1036-1047.
41. Ersche K.D., Roiser J.P., Robbins T.W., Sahakian B.J. Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans. Psychopharmacology 2008, 197(3):421-431.
42. European Monitoring Centre for Drugs and Drug Addiction Annual Report, 2008. The state of the drugs problem in the European. Available at EMCDDA, Lisbon. http://www.emcdda.eu/.
43. Everitt B.J., Robbins T.W. Neural systems of reinforcement of drug addiction: from actions to habits to compulsion. Nat. Neurosci. 2005, 8:1481-1489.
44. Fadda P., Robinson L., Fratta W., Pertwee R.G., Riedel G. Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats. Neuropharmacology 2004, 47(8):1170-1179.
45. Fein G., Di Sclafani V., Meyerhoff D.J. Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. Drug Alcohol Depend. 2002, 68:87-93.
46. Fein G., Klein L., Finn P. Impairment on a simulated gambling task in long-term abstinent alcoholics. Alcohol. Clin. Exp. Res. 2004, 28(10):1487-1491.
47. Fein G., Torres J., Price L.J., Di Sclafani V. Cognitive performance in long-term abstinent alcoholics. Alcohol. Clin. Exp. Res. 2006, 30:1538-1544.
48. Fernández-Serrano, M.J., Lozano, O., Pérez-García, M., Verdejo-García, A. Impact of severity of drug use on discrete emotions recognition in polysubstance abusers. Drug Alcohol Depend., in press-a.
49. Fernández-Serrano M.J., Pérez-García M., Perales J.C., Verdejo-García A. Prevalence of executive dysfunction in cocaine, heroin and alcohol users enrolled in therapeutic communities. Eur. J. Pharmacol. 2010, 626:104-112.
50. Fernández-Serrano, M.J., Pérez-García, M., Schmidt Río-Valle, J., Verdejo-García, A. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions. J. Psychopharmacol., in press-b.
51. Field M., Cox W.M. Attentional bias in addictive behaviors: a review of its development, causes, and consequences. Drug Alcohol Depend. 2008, 97(1):20.
52. Fillmore M.T., Rush C.R. Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend. 2002, 66:265-273.
53. Fillmore M.T., Rush C.R., Hays L. Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend. 2002, 67:157-167.
54. Fillmore M.T., Rush C.R., Hays L. Cocaine improves inhibitory control in human model of response conflict. Exp. Clin. Psychopharmacol. 2005, 13:327-335.
55. Fillmore M.T., Rush C.R., Hays L. Acute effects of cocaine in two models of inhibitory control: implications of non-linear dose effects. Addiction 2006, 101(9):1323-1332.
56. Fishbein D.H., Krupitsky E., Flannery B.A., Langevin D.J., Bobashev G., Verbitskaya E., Augustine C.B., Bolla K.I., Zvartau E., Schech B., Egorova V., Bushara N., Tsoy M. Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug Alcohol Depend. 2007, 90:25-38.
57. Fisk J.E., Montgomery C. Evidence for selective executive functions deficits in ecstasy/polydrug users. J. Psychopharmacol. 2009, 23:40-50.
58. Foisy M.L., Kornreich C., Fobe A., D'Hondt L., Pelc I., Hanak C., Verbanck P., Philippot P. Impaired emotional facial expression recognition in alcohol dependence: do these deficits persist with midterm abstinence?. Alcohol. Clin. Exp. Res. 2007, 31(3):404-410.
59. Fox H.C., McLean A., Turner J.J.D., Parrot A.C., Rogers R., Sahakian B.J. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (" ecstasy") polydrug users. Psychopharmacology 2002, 162:203-214.
60. Franken I.H.A., Nijs I.M.T., Muris P., Van Strien J.W. Alcohol selectively reduces brain activity during the affective processing of negative information. Alcohol. Clin. Exp. Res. 2007, 31(6):919-927.
61. Frederick D.L., Ali S.F., Gillam M.P., Gossett J., Slikker W., Paule M.G. Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment. Ann. N.Y. Acad. Sci. 1998, 844:183-190.
62. Frederick D.L., Ali S.F., Slikker W., Gillam M.P., Allen R.R., Paule M.G. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Neorotoxicol. Teratol. 1995, 17:531-543.
63. Fried P.A., Watkinson B., Gray R. Neurocognitive consequences of marihuana-a comparison with pre-drug performance. Neurotoxicol. Teratol. 2005, 27:231-239.
64. Friswell J., Phillips C., Holding J., Morgan C.J.A., Brandner B., Curran H.V. Acute effects of opioids on memory functions on healthy men and women. Psychopharmacology 2008, 198:243-250.
65. Garavan H., Hester R. The role of cognitive control in cocaine dependence. Neuropsychol. Rev. 2007, 17(3):337-345.
66. Garavan H., Kaufman J.N., Hester R. Acute effects of cocaine on the neurobiology of cognitive control. Philos. Trans. R. Soc. B 2008, 363:3267-3276.
67. Gerra G., Baldaro B., Zaimovic A., Moi G., Bussandri M., Raggi M.A., Brambilla F. Neuroendocrine responses to experimentally-induced emotions among abstinence opioid-dependent subjetcs. Drug Alcohol Depend. 2003, 71(1):25-35.
68. Goldstein R.Z., Leskovjan A.C., Hoff A.L., Hitzemann R., Bashan F., Khalsa S.S., Wang G., Fowler J.S., Volkow N.D. Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia 2004, 42:1447-1458.
69. Goldstein R.Z., Tomasi D., Rajaram S., Cottone L.A., Zhang L., Maloney T., Telang F., Alia-Klein N., Volkow N.D. Role of the anterior cingulated and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience 2007, 144:1153-1159.
70. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 2002, 159:1642-1652.
71. Goldstein R.Z., Woicik P.A., Lukasik T., Maloney T., Volkow N.D. Drug fluency: a potential marker for cocaine use disorders. Drug Alcohol Depend. 2007, 89:97-101.
72. González R., Bechara A., Martin E.M. Executive functions among individuals with methamphetamine or alcohol as drugs of choice: preliminary observations. J. Clin. Exp. Neuropsychol. 2007, 29(2):155-159.
73. González R., Rippeth J.D., Carey C.L., Heaton R.K., Moore D.J., Shweinsburg B.C., Cherner M., Grant I. Neurocognitive performance of methamphetamine users discordante for history of marijuana exposure. Drug Alcohol Depend. 2004, 76:181-190.
74. Gouzoulis-Mayfrank E., Daumann J., Tuchtenhagen F., Pelz S., Becker S., Kunert J., Fimm B., Sass H. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J. Neurol. Neurosurg. Psychiatry 2000, 68:719-725.
75. Gouzoulis-Mayfrank E., Thimm B., Rezk M., Hensen G., Daumann J. Memory impairment suggest hippocampal dysfunction in abstinent ecstasy abusers. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27:819-827.
76. Grant I., González R., Carey C.L., Natarajan L., Wolfson T. Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J. Int. Neuropsychol. Soc. 2003, 9:679-689.
77. Hammersley R., Ditton J., Smith I., Short E. Patterns of ecstasy use by drug users. Br. J. Criminol. 1999, 39:625-647.
78. Halpern J.H., Pope H.G., Sherwood A.R., Barry S., Hudson J.I., Yurgelun-Todd D. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend. 2004, 75:135-147.
79. Heath R.G., Fitziarrell A.T., Fontana C.J., Garey R.E. Cannabis sativa: effects on brain function and ultrastructure in rhesus monkeys. Biol. Psychiatry 1980, 15(5):657-690.
80. Heil S.H., Johnson M.W., Higgins S.T., Bickel W.K. Delay discounting in currently using and currently abstinent cocaine-dependent outpatients and non-drug-using matched controls. Addict. Behav. 2006, 31(7):1290-1294.
81. Henry J.D., Mazur M., Rendell P.G. Social-cognitive difficulties in former users of methamphetamine. Br. J. Clin. Psychol. 2009, 48:323-327.
82. Herkenham M. Cannabinoid receptor localization in brains: relationship to motor and reward systems. Ann. N. Y. Acad. Sci. 1992, 654:19-32.
83. Hoffman W.F., Moore M., Templin R., McFarland B., Hitzemann R.J., Mitchell S.H. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology 2006, 188:162-170.
84. Hoshi R., Bisla J., Curran H.V. The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings. Drug Alcohol Depend. 2004, 76:297-304.
85. Hoshi R., Mullins K., Boundy C., Brignell C., Piccini P., Curran H.V. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls. Psychopharmacology 2007, 194:371-379.
86. Ilan A.B., Smith M.E., Gevins A. Effects of marijuana on neurophysiological signals of working and episodic memory. Psychopharmacology 2004, 176:214-222.
87. Jatlow P., McCance E.F., Bradberry C.W., Elsworth J.D., Taylor J.R., Roth R.H. Alcohol plus cocaine: the whole is more than the sum of its parts [proceedings of the fourth international congress of therapeutic drug monitoring and clinical toxicology]. Ther. Drug Monit. 1996, 18(4):460-464.
88. Jentsch J.D., Olausson P., De la Garza R., Taylor J.R. Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys. Neuropsychopharmacology 2002, 26(2):183-190.
89. 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat. Neurosci. Lett. 1998, 246(3):169-172.
90. Johnson B.A., Ait-Daoud N., Wells L.T. Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on d-methamphetamine-induced cognitive and physiological changes in humans. Neuropsychopharmacology 2000, 22:504-512.
91. Jovanovski D., Erb S., Zakzanis K. Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J. Clin. Exp. Neuropsychol. 2005, 27:189-204.
92. Kalechstein A.D., Newton T.F., Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J. Neuropsychiatry Clin. Neurosci. 2003, 15(2):215-220.
93. Kemmis L., Hall J.K., Kingston R., Morgan M.J. Impaired fear recognition in regular recreational cocaine users. Psychopharmacology 2007, 194(2):151-159.
94. Kirisci L., Tarter R.E., Reynolds M., Vanyukov M. Individual differences in childhood neurobehavior disinhibition predict decision to desist substance use during adolescence and substance use disorder in young adulthood: a prospective study. Addict. Behav. 2006, 31:686-696.
95. Kirisci L., Vanyukov M., Tarter R. Detection of youth at high risk for substance use disorders: a longitudinal study. Psychol. Addict. Behav. 2005, 19:243-252.
96. Klintsova A.Y., Helfer J.L., Calizo L.H., Dong W.K., Goodlett C.R., Greenough W.T. Persistent impairment of hippocampal neurogenesis in young adult rats following early postnatal alcohol exposure. Alcohol. Clin. Exp. Res. 2007, 31(12):2073-2082.
97. Kornreich C., Foisy M.L., Philippot P., Dan B., Tecco J., Noël X., Hess U., Pelc I., Verbanck P. Impaired emotional facial expression recognition in alcoholics, opiate dependence subjects, methadone maintained subjects and mixed alcohol-opiate antecedents subjects compared with normal controls. Psychiatry Res. 2003, 119(3):251-260.
98. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
99. Krull K.R., Adams R.L. Problems in neuropsychological research methodology. Clinical Neuropsychology: Theoretical Foundations for Practitioners 1997, M.E. Maruish, J.A. Moses (Eds.).
100. Kufahl P.R., Zhu Li, Risinger R.C., Rainey C.J., Wu G., Bloom A.S., Li S. Neural responses to acute cocaine administration in the human brain detected by fMRI. Neuroimage 2005, 28(4):904-914.
101. Kuypers K.P., Ramaekers J.G. Acute dose of MDMA (75mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected. Psychopharmacology 2007, 189:557-563.
102. Kuypers K.P.C., Wingen M., Samyn N., Limbert N., Ramaekers J.G. Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night. Psychopharmacology 2007, 192(1):111-119.
103. Kirby K.N., Petry N.M. Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls. Addiction 2004, 99:461-471.
104. Lane S.D., Cherek D.R., Tcheremissine O.V., Lieving L.M., Pietras C.J. Acute marijuana effects on human risk taking. Neuropsychopharmacology 2005, 30:800-809.
105. Leitz J.R., Morgan C.J.A., Bisby J.A., Rendell P.G., Curran V. Global impairment of prospective memory following acute alcohol. Psychopharmacology 2009, 205(3):379-387.
106. Lyons M.J., Bar J.L., Panizzon M.S., Toomey R., Eisen S., Xian H., Tsuang M.T. Neuropsychological consequences of regular marijuana use: a twin study. Psychol. Med. 2004, 34:1239-1250.
107. Lyvers M., Yakimoff M. Neuropsychological correlates of opioid dependence and withdrawal. Addict. Behav. 2003, 28:605-611.
108. McCann U.D., Szabo Z., Seckin E., Rosenblatt P., Mathews W.B., Ravert H.T., Dannals R.F., Ricaurte G.A. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB. Neuropsychopharmacology 2005, 30:1741-1750.
109. McHale S., Hunt N. Executive function deficits in short-term abstinent cannabis users. Hum. Psychopharmacol. Clin. Exp. 2008, 23:409-415.
110. Medina K.L., Hanson K.L., Schweinsburg A.D., Cohen-Zion M., Nagel B.J., Tapert S.F. Neuropsychogical functioning in adolescent marijuana users: Subtle deficits detectable after a month of abstinence. J. Int. Neuropsychol. Soc. 2007, 13:807-820.
111. Medina K.L., McQueeny T., Nagel B.J., Hanson K.L., Schweinsburg A.D., Tapert S. Prefrontal cortex volumes in adolescents with alcohol use disorders: unique gender effects. Alcohol. Clin. Exp. Res. 2008, 32(3):386-394.
112. Medina K.L., McQueeny T., Nagel B.J., Hanson K.L., Yang T.T., Tapert S.F. Prefrontal cotex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addict. Biol. 2009, 14(4):457-468.
113. Metzger D.S., Woody G., Marmor M., Gross M. Risk characteristics of injection drug users (IDUs) participating in the vaccine preparedness study (VPS). Int. Conf. AIDS 1996, 11:357.
114. Miller N.S., Gold M.S., Belkin B.M. The diagnosis of alcohol and cannabis dependence in cocaine dependence. Adv. Alcohol Subst. Abuse 1990, 8:33-42.
115. Mintzer M.Z., Copersino M.L., Stitzer M.L. Opioid abuse and cognitive performance. Drug Alcohol Depend. 2005, 78:225-230.
116. Monterosso J.R., Aron A.R., Cordova X., Xu J., London E.D. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend. 2005, 79:273-277.
117. Montgomery C., Fisk J.E., Newcombe R., Murphy P.N. The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory. Psychopharmacology 2005, 182:262-276.
118. Moon M., Do K.S., Park J., Kim D. Memory impairment in methamphetamine dependent patients. Int. J. Neurosci. 2007, 117:1-9.
119. Morgan M.J. Recreational use of MDMA (" ecstasy") is associated with elevated impulsivity. Neuropsychopharmacology 1998, 19:252-264.
120. Morgan M.J. Memory deficits associated with recreational use of 'ecstasy' (MDMA). Psychopharmacology 1999, 141:30-36.
121. Morgan M.J., Impallomeni L.C., Pirona A., Rogers R.D. Elevated impulsivity and impaired decision-making in abstinent ecstasy (MDMA) users compared to polydrug and drug-naïve controls. Neuropsychopharmacology 2006, 31:1562-1573.
122. Nagai T., Takuma K., Dohniwa M., Ibi D., Mizoguchi H., Kamei H., Nabeshima T., Yamada K. Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol. Psychopharmacology 2007, 194(1):21-32.
123. 9-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze. Neuropharmacology 2001, 41(3):392-399.
124. Niyuhire F., Varvel S.A., Martin B.R., Lichtman A.H. Exposure to marijuana smoke impairs memory retrieval in mice. J. Pharmacol. Exp. Ther. 2007, 322:1067-1075.
125. O'Leary-Moore S.K., McMechan A.P., Mathison S.N., Berman R.F., Hannigan J.H. Reversal learning after prenatal or early postnatal alcohol exposure in juvenile and adult rats. Alcohol 2006, 38(2):99-110.
126. Ornstein T.J., Iddon J.L., Baldacchino A.M., Sahakian B.J., London M., Everitt B.J., Robbins T.W. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 2000, 23:113-126.
127. Paine T.A., Dringenberg H.C., Olmstead M.C. Effects of chronic cocaine on impulsivity: relation to cortical serotonin mechanisms. Behav. Brain Res. 2003, 147:135-147.
128. Pau C.W.H., Lee T.M.C., Chan S.F. The impact of heroin on frontal executive functions. Arch. Clin. Neuropsychol. 2002, 17:663-670.
129. Pitel A.L., Beaunieux H., Witkowski T., Vabret F., Guillery-Girard B., Quinette P., Desgranges B., Eustache F. Genuine episodic memory deficits and executive dysfunctions in alcoholics early in abstinence. Alcoholism 2007, 31(7):1169-1178.
130. Pope H.G., Gruber A.J., Hudson J.L., Huestis M.A., Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch. Gen. Psychiatry 2001, 58:909-915.
131. Prosser J., Cohen L.J., Steinfeld M., Eisenberg D., London E.D., Galynker I.I. Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Acohol Depend. 2006, 84(3):240-247.
132. Pu L., Bao G.B., Xu N.J., Ma L., Pei G. Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. J. Neurosci. 2002, 22:1914-1921.
133. Quednow B.B., Kühn K.U., Hoppe C., Westheide J., Maier W., Daum I., Wagner M. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA (" Ecstasy"). Psychopharmacology 2007, 189(4):517-530.
134. Quednow B.B., Kuhn K.U., Hoppe C., Westheide J., Maier W., Wagner M. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction. Psychopharmacology 2006, 20:1-14.
135. Ramaekers J.G., Kauert G., van Ruitenbeek P., Theunissen E.L., Schneider E., Moeller M.R. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 2006, 31:2296-2303.
136. Ramaekers J.G., Kuypers K.P.C. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioural measures of impulsivity: alone and in combination with alcohol. Neuropsychopharmacology 2006, 31:1048-1055.
137. Ranganathan M., D'Souza D.C. The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology 2006, 188:425-444.
138. Ratti M.T., Giardini P., Soragna D. Chronic alcoholism and the frontal lobe: which executive functions are imparied?. Acta Neurol. Scand. 2002, 105(4):276-281.
139. Ray S., Bates M.E. Acute alcohol effects on repetition priming and word recognition memory with equivalent memory cues. Brain Cogn. 2006, 60(2):118-127.
140. Rendell P.G., Mazur M., Henry J.D. Prospective memory impairment in former users of methamphetamine. Psychopharmacology 2009, 203:609-616.
141. Ricaurte G.A., Yuan J., Hatzidimitriou G., Cord B.J., McCann U.D. Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA (" Ecstasy"). Science 2002, 297:2260-2263.
142. Robinson J.E., Heaton R.K., Oómalley S.S. Neuropsychological functioning in cocaine abusers with and without alcohol dependence. J. Int. Neuropsychol. Soc. 1999, 5:10-19.
143. Roiser J.P., Rogers R.D., Sahakian B.J. Neuropsychological function in ecstasy users: a study controlling for polydrug use. Psychopharmacology 2007, 189:505-516.
144. Roselli M., Ardila A. Cognitive effects of cocaine and polydrug abuse. J. Clin. Exp. Neuropsychol. 1996, 18:122-135.
145. Rounsaville B.J., Foley S., Carroll K., Budde D., Prusoff B.A., Gawin F.H. Psychiatric diagnosis of treatment seeking cocaine abusers. Arch. Gen. Psychiatry 1991, 48:43-51.
146. Salo R., Nordahl T.E., Galloway G.P., Moore C.D., Waters C., Leamon M.H. Drug abstinence and cognitive control in methamphetamine-dependent individuals. J. Subst. Abuse Treat. 2009, 37:292-297.
147. Salo R., Nordahl T.E., Possin K., Leamon M., Gibson D.R., Galloway G.P., Flynn N.M., Henik A., Pfefferbaum A., Sullivan E.V. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res. 2002, 111(1):65-74.
148. Sánchez-Tutret, M., 1997. Alcohol y alcoholismo. En Gómez-Jarabo, G. (Ed.), Farmacología de la conducta. Manual básico para psicoterapeutas y clínicos. Síntesis, S.A., Madrid.
149. Santucci A.C., Capodilupo S., Bernstein J., Gómez-Ramírez M., Milefsky R., Mitchell H. Cocaine in adolescent rats produces residual memory impairments that are reversible with time. Neurotoxicol. Teratol. 2004, 26(5):651-661.
150. Schilt T., de Win M.M.L., Jager G., Koeter M.W., Ramsey N.F., Schmand B., van den Brink W. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychol. Med. 2008, 38:1309-1317.
151. Schoenbaum G., Saddoris M.P., Ramus S.J., Shaham Y., Setlow B. Cocaine-experienced rats exhibit learning deficits in a task sensitive to orbitofrontal cortex lesions. Eur. J. Neurosci. 2004, 19:1997-2002.
152. Schottenbauer M.A., Hommer D., Weingartner H. Memory deficits among alcoholics: performance on a selective reminding task. Aging Neuropsychol. Cogn. 2007, 14:505-516.
153. Schütz C.G., Vlahov D., Anthony J.C., Graham N.M.H. Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. J. Clin. Epidemiol. 1994, 47:191-195.
154. Silber B.Y., Croft R.J., Papafotiou K., Stough C. The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology 2006, 187:154-169.
155. Simon N.W., Mendez I.A., Setlow B. Cocaine exposure causes long-term increases in impulsive choice. Behav. Neurosci. 2007, 121(3):543-549.
156. Solowij N., Battisti R. The chronic effects of cannabis on memory in humans: a review. Curr. Drug Abuse Rev. 2008, 1:81-98.
157. Spain J.W., Newsom G.C. Chronic opioids impair acquisition of both radial maze and Y-maze choice escape. Psychopharmacology 1991, 105:101-106.
158. Stalnaker T.A., Roesch M.R., Franz T.M., Burke K.A., Schoenbaum G. Abnormal associative encoding in orbitofrontal neurons in cocaine-experienced rats during decision-making. Eur. J. Neurosci. 2006, 24:2643-2653.
159. Stalnaker T.A., Takahashi Y., Roesch M.R., Schoenbaum G. Neural substrates of cognitive inflexibility after chronic cocaine exposure. Neuropharmacology 2009, 56:63-72.
160. Taffe M.A., Davis S.A., Yuan J., Schroeder R., Hatzidimitriou G., Parsons L.H., Ricaurte G.A., Gold L.H. Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge. Neuropsychopharmacology 2002, 27:993-1005.
161. Taffe M.A., Huitron-Resendiz S., Schroeder R., Parsons L.H., Henriksen S.J., Gold L.H. MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys. Pharmacol. Biochem. Behav. 2003, 76:141-152.
162. Tarter R.E., Kirisci L., Habeych M., Reynolds M., Vanyukov M. Neurobehavior disinhibition in childhood predisposes boys to substance use disorder by young adulthood: direct and mediated etiologic pathways. Drug Alcohol Depend. 2004, 73:121-132.
163. Tucker K.A., Potenza M.N., Beauvais J.E., Browndyke J.N., Gottschalk C., Kosten T.R. Perfusion abnormalities and decision-making in cocaine dependence. Biol. Psychiatry 2004, 56:527-530.
164. van Gorp W.G., Wilkins J.N., Hinkin C.H., Moore L.H., Hull J., Horner M.D., Plotkin D. Declarative and procedural memory functioning in abstinent cocaine abusers. Arch. Gen. Psychiatry 1999, 56:85-89.
165. van der Plas E.A.A., Crone E.A., van den Wildenberg W.P.M., Tranel D., Bechara A. Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women. J. Clin. Exp. Neuropsychol. 2009, 31:706-719.
166. Verdejo-García A., Bechara A. A somatic marker theory of addiction. Neuropharmacology 2009, 56:48-62.
167. Verdejo-García A., Bechara A., Recknor E.C., Pérez García M. Decision-making and the Iowa gambling task: ecological validity in individuals with substance dependence. Psychol. Belg. 2006, 46:55-78.
168. Verdejo-García A., Benbrook A., Funderburk F., David P., Cadet J.L., Bolla K.I. The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task. Drug Alcohol Depend. 2007, 90(2):11.
169. Verdejo-García A., Lawrence A.J., Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci. Biobehav. Rev. 2008, 32:777-810.
170. Verdejo-García A., López-Torrecillas F., Giménez C.O., Pérez-García M. Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. Neuropsychol Rev. 2004, 14(1):1-41.
171. Verdejo-García A., López Torrecillas F., Aguilar de Arcos F., Pérez García M. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addict. Behav. 2005, 30(1):89-101.
172. Verdejo-García A., Perales J.C., Pérez-García M. Cognitive impulsivity in cocaine and heroin polysubstance abusers. Addict. Behav. 2007, 32:950-966.
173. Verdejo-García A., Pérez-García M. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology 2007, 190:517-530.
174. Verdejo-García A., Pérez-García M. Ecological assessment of executive functions in substance dependent individuals. Drug Alcohol Depend. 2007, 90:48-55.
175. Verdejo-García A., Rivas-Pérez C., Vilar-López R., Pérez García M. Strategic self-regultaion, decision-making and emotion processing in poly-substance abusers in their first year of abstinence. Drug Alcohol Depend. 2007, 86:139-146.
176. Verdejo-García A., Toribio C., Orozco K., Puente K., Pérez García M. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend. 2005, 78:283-288.
177. Vericco C.D., Jentsch J.D., Roth R.H. Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, interminttent, cannabinoid administration to rats. Synapse 2003, 49:61-66.
178. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., Gatley S.J., Miller E., Hitzemann R., Ding Y.S., Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 2001, 21:9414-9418.
179. Vollenweider F.X., Lechti M.E., Paulus M.P. MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task. J. Psychopharmacol. 2005, 19:366-374.
180. Wadsworth E.J.K., Moss S.C., Simpson S.A., Smith A.P. Cannabis use, cognitive performance and mood in a sample of workers. J. Psychopharmacol. 2006, 20(1):14-23.
181. Ward J., Hall K., Haslam C. Patterns of memory dysfunction in current and 2-year abstinent MDMA users. J. Clin. Exp. Neuropsychol. 2006, 28:306-324.
182. Wareing M., Fisk J.E., Murphy P., Montgomery C. Verbal working memory deficits in current and previous users of MDMA. Hum. Psychopharmacol. Clin. Exp. 2004, 19:225-234.
183. Wareing M., Fisk J.E., Murphy P., Montgomery C. Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy'). Hum. Psychopharmacol. Clin. Exp. 2005, 20:115-123.
184. Wilson B.A., Alderman N.A., Burgess P.W., Ernslie H., Evans J.J. Behavioural Assessment of the Dysexecutive Syndrome 1996, Thames Valley Test Company, Bury St. Edmunds.
185. Wilson S.J., Sayette M.A., Fiez J.A. Prefrontal responses to drug cues: a neurocognitive analysis. Nat. Neurosci. 2004, 7(3):211-214.
186. Woicik P.A., Moeller S., Alia-Klein N., Maloney T., Lukasik T.M., Yeliosof O., Wang G.J., Volkow N.D., Goldstein R.Z. The neuropsychology of cocaine addiction: recent cocaine use masks impairment. Neuropsychopharmacology 2008, 1:11.
187. Woods S.P., Rippeth J.D., Conover E., Gongvatana A., González R., Carey C.L., Cherner M., Heaton R.K., Grant I. Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology 2005, 19(1):35-43.
188. Wu L.T., Parrott A.C., Ringwalt C.L., Patkar A.A., Mannelli P., Blazer D.G. The high prevalence of substance use disorders among recent MDMA users compared with other drug users: implications for intervention. Addict. Behav. 2009, 34(8):654-661.
189. Yip J., Lee T. Effect of ecstasy use on neuropsychological function: a study in Hong Kong. Psychopharmacology 2005, 179:620-628.
190. Zakzanis K.K., Campbell Z., Jovanovski D. The neuropsychology of ecstasy (MDMA) use: a quantitative review. Hum. Psychopharmacol. 2007, 22(7):427-435.
191. Zakzanis K.K., Young D.A. Executive function in abstinent MDMA ('ecstasy') users. Med. Sci. Monit. 2001, 7:1292-1298.
192. Zakzanis K.K., Young D.A., Campbell Z. Prospective memory impairment in abstinent MDMA (" ecstasy") users. Cogn. Neuropsychiatry 2003, 8(2):141-153.